SB-269970 hydrochloride

For research use only. Not for therapeutic Use.

  • CAT Number: I002897
  • CAS Number: 261901-57-9
  • Molecular Formula: C18H28N2O3S • HCl
  • Molecular Weight: 389.00
  • Purity: ≥95%
Inquiry Now

SB-269970 hydrochloride(Cat No.:I002897)is a selective antagonist of the 5-HT7 serotonin receptor, widely used in neuroscience research to explore the role of this receptor in regulating mood, cognition, and circadian rhythms. By blocking 5-HT7 receptor activity, SB-269970 hydrochloride provides insights into potential treatments for psychiatric and neurological disorders, such as depression, anxiety, and schizophrenia. Its high specificity and potency make it an essential tool in studying serotonin-mediated signaling pathways, offering a valuable contribution to the development of novel therapeutics targeting mental health conditions.


Catalog Number I002897
CAS Number 261901-57-9
Synonyms

3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol;hydrochloride

Molecular Formula C18H28N2O3S • HCl
Purity ≥95%
Target Neuronal Signaling
Solubility DMSO: ≥ 30 mg/mL
Storage 3 years -20C powder
IC50 8.3 (pKi for 5-HT7)
IUPAC Name 3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol;hydrochloride
InChI InChI=1S/C18H28N2O3S.ClH/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18;/h2,5-6,14-16,21H,3-4,7-13H2,1H3;1H/t16-;/m1./s1
InChIKey XQCJOYZLWFNDIO-PKLMIRHRSA-N
SMILES CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O.Cl
Reference

<p style=”/line-height:25px/”>
<br />
[1]. http://www.ncbi.nlm.nih.gov/pubmed/10821781<br />
[2]. Roberts C, et al. The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies. Br J Pharmacol. 2001 Apr;132(7):1574-80.<br />
[3]. Roberts C, et al. The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies. Br J Pharmacol. 2001 Apr;132(7):1574-80.<br />
[4]. Monti JM, et al. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat. Behav Brain Res. 2008 Aug 22;191(2):184-9.</p>

Request a Quote